Login / Signup

Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review.

Clara FatoyeGillian YeowellEula MillerIsaac OdeyemiChidozie Emmanuel Mbada
Published in: Journal of market access & health policy (2024)
Market access in pharma is a process that commences with the development and availability of the right products that are proven to be efficacious and disease/condition-specific (including medications, medical devices, and vaccines); specifically produced for the right patients or end users who will maximise best clinical outcomes and economic value; delivered at the right point in a timely, sustained, and efficient manner, given at the right price (commercially viable or reimbursed price that represents good value); and conducted within the economic, policy, societal, and technological contexts, with the overarching goal of achieving the best patient outcomes and ensuring product profitability.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • healthcare
  • health insurance
  • public health
  • prognostic factors
  • mental health